Seres Therapeutics (NASDAQ:MCRB) Upgraded at Wall Street Zen

Seres Therapeutics (NASDAQ:MCRB – Get Free Report) was upgraded by Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Saturday. Other equities analysts also recently issued research reports about the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $22.00 […]